Growth Hormone Peptides Hexarelin Steroid Peptide CAS 140703-51-1 HEX Examorelin For Cutting Cycle

Growth Hormone Peptides Hexarelin Steroid Peptide CAS 140703-51-1 HEX Examorelin For Cutting Cycle

Quick Details:

Name	Hexarelin
Synonyms	Hexarelin Acetate, HEX, Examorelin
Classification	Growth Hormone Peptides
CAS number	140703-51-1
Molecular formula	C47H58N12O6
MW	887.04022
MS
HS Code	2937190090
Appearance	White Powder
Purity	98%
Storage	Closed, below 2 ~ 8℃ preservation
Delivery time	within 24 hours upon receipt of payment
Delivery	EMS, DHL, TNT, FedEx, UPS

Product Description:

Hexarelin is a peptide and it’s utilized in order to access performance-enhancing benefits. Athletes and bodybuilders are examples of men and women who use this peptide in order to improve their strength and endurance, as well as their muscle mass and fat-burning power.

This potent peptide is sold in injectable formats and it sparks the natural production of GH, which is Growth Hormone. Growth Hormone may also be referred to as HGH. As we get older, our bodies produce less of this vital hormone, which makes it harder for us to build lean muscle, burn calories and feel (and look) youthful.

Injecting Hexarelin is therefore one of the keys to feeling younger and stronger. This peptide hormone will help users to build attractive figures or physiques.

Nicknamed “Hex”, this peptide growth hormone secretagogue has a similar chemical structure to GHRP-6. It may be used in order to treat symptoms of Growth Hormone deficiency.

The primary function of this peptide is to boost growth hormone levels via stimulations of the pituitary gland. It works as other GHRPs do, via a two-fold action which triggers increased production of Growth Hormone by boosting the signal transduction pathway of GH. It also gets results by inhibiting the action of Somatostatin.

Growth hormone secretagogue receptor is a G protein-coupled receptor that binds ghrelin and plays a role in energy homeostasis and regulation of body weight.

Hexarelin is a six-amino acid peptide. Studies have shown that hexarelin is actually more effective and longer lasting than growth hormone releasing hormone (GHRH). It is also known that GHRP-6 has a synergistic effect with GHRH, causing a far greater release than either of these substances alone. By combining GHRP-6 with Hexarelin, a more potent GH releasing peptide combination is created than ever heard of. The potential clinical usefulness of these GH releasing hexapeptides is also reinforced by observations that long-term administration produces elevations in circulating IGF-1 concentrations. Long term treatment with GHRP-6 similarly has been shown to elevate serum IGF-1 as well as IGF-binding protein-3 concentrations and promote linear growth.

Application:

Ghrelin is an appetite-regulating factor secreted from peripheral organs that is involved in regulation of energy homoeostasis via binding to the receptor resulting in the secretion of growth hormone by the pituitary gland. The pathway activated by binding of ghrelin to the growth hormone secretagogue receptor, GHSR1a, regulates the activation of the downstream mitogen-activated protein kinase, Akt, nitric oxide synthase, and AMPK cascades in different cellular systems. One of the important features of GHSR1a displays constitutive activity possessing basal activity in the absence of an agonist, resulting in a high degree of receptor internalization as well as of signaling activity.Inverse agonists for the ghrelin receptor could be particularly interesting for the treatment of obesity.This activity seems to provide a tonic signal required for the development of normal height, probably through an effect on the GH axis.

Ghrelin is an appetite-regulating factor secreted from peripheral organs that is involved in regulation of energy homoeostasis via binding to the receptor resulting in the secretion of growth hormone by the pituitary gland. The pathway activated by binding of ghrelin to the growth hormone secretagogue receptor, GHSR1a, regulates the activation of the downstream mitogen-activated protein kinase, Akt, nitric oxide synthase, and AMPK cascades in different cellular systems.

One of the important features of GHSR1a displays constitutive activity possessing basal activity in the absence of an agonist, resulting in a high degree of receptor internalization as well as of signaling activity.Inverse agonists for the ghrelin receptor could be particularly interesting for the treatment of obesity.This activity seems to provide a tonic signal required for the development of normal height, probably through an effect on the GH axis.